Chondroitin Sulfate Nanovectorized by LC-PUFAs Nanocarriers Extracted from Salmon (Salmo salar) by Green Process with Decreased Inflammatory Marker Expression in Interleukin-1β-Stimulated Primary Human Chondrocytes In Vitro Culture
2024

Using Salmon By-Products to Create Anti-Inflammatory Liposomes

Sample size: 6 publication 10 minutes Evidence: moderate

Author Information

Author(s): Pruvost Louis, Gerlei Maureen, Paris Cédric, Velot Émilie, Kahn Cyril J.-F., Bianchi Arnaud, Linder Michel

Primary Institution: Université de Lorraine

Hypothesis

Can chondroitin sulfate and lipids extracted from salmon heads reduce inflammation in human chondrocytes?

Conclusion

The study found that liposomes containing chondroitin sulfate effectively reduced inflammation in human chondrocytes.

Supporting Evidence

  • Chondroitin sulfate has known anti-inflammatory properties.
  • Marine lipids are rich in long-chain fatty acids that can reduce inflammation.
  • Low concentrations of chondroitin sulfate in liposomes still showed positive effects on inflammation.

Takeaway

Researchers made tiny bubbles called liposomes from salmon parts and found they can help reduce swelling in joint cells.

Methodology

Chondroitin sulfate and lipids were extracted from salmon heads using enzymatic processes, then formulated into liposomes and tested on human chondrocytes under inflammatory conditions.

Limitations

The study was limited to in vitro conditions and used a small sample size of human chondrocytes.

Participant Demographics

Human chondrocytes were sourced from 6 osteoarthritis patients aged 70 ± 9 years.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3390/md22120571

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication